Abaloparatide versus Placebo for Pelvic Fracture Healing - A Phase 2 Randomized Controlled Trial

Go Back to All Clinical Trials

Abaloparatide versus Placebo for Pelvic Fracture Healing - A Phase 2 Randomized Controlled Trial

Brief description of study

The purpose of this study is to determine whether Abaloparatide, also known as Tymlos can help to heal a broken bone (fracture) in the pelvis (part of your hip) more quickly than the standard treatment. This study will examine whether 3 months of Abaloparatide (Tymlos) injections will help your bones to heal quicker, reduce your pain and help you to move sooner as compared to a placebo injection (filled with inactive ingredients). After 3 months, the participant will be able to go on a treatment of your choice and be followed for the rest of the year. The overall participation will continue over the course of 12 months.

Clinical Study Identifier: s20-00894

ClinicalTrials.gov Identifier: NCT04249232

Principal Investigator: Kenneth A Egol.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies